Skip to main content
Top
Published in: Endocrine 3/2014

01-12-2014 | Endocrine Genetics/Epigenetics

Polymorphisms in NR3C1 gene associated with risk of metabolic syndrome in a Chinese population

Authors: Yu-Xiang Yan, Jing Dong, Jie Zhang, Fen Liu, Wei Wang, Ling Zhang, Yan He

Published in: Endocrine | Issue 3/2014

Login to get access

Abstract

Polymorphisms of the NR3C1 (glucocorticoid receptor) gene have been reported to be associated with altered glucocorticoids sensitivity and changes in body composition and metabolic parameters. This study explored the relationship between single nucleotide polymorphisms (SNPs) of the NR3C1 gene and metabolic syndrome (MetS) in a Chinese population. Fourteen tag-SNPs and five functionally important SNPs in the NR3C1 gene were genotyped in MetS patients (n = 431) and normal controls (n = 461) using the high-throughput Sequenom genotyping platform. Genotype, allelic and haplotype associations were examined using logistic regression and Haploview. There are four SNPs significantly associated with MetS. The T allele of rs2963156 was associated with an increased risk effect for MetS (adjusted OR = 1.66, 95 % CI 1.25–2.22, P = 0.001). By contrast, rs10052957 A allele carriers were significantly associated with a decreased risk of MetS (adjusted OR = 0.58, 95 % CI 0.42–0.80, P = 0.001). Rs41423247 GG genotype (adjusted OR = 2.01, 95 % CI 1.25–3.22, P = 0.004), and rs7701443 AA genotype (adjusted OR = 1.88, 95 % CI 1.24–2.83, P = 0.003) were significantly associated with an increased risk of MetS. Haplotype CGGA is risk conferring (adjusted OR = 1.53, 95 % CI 1.06–2.20, P = 0.023), whereas haplotype CCAG was protective (adjusted OR = 0.30, 95 % CI 0.20–0.47, P < 0.001). Polymorphism of NR3C1 gene is associated with MetS and may contribute to the susceptibility of MetS.
Appendix
Available only for authorised users
Literature
1.
go back to reference D.E. Moller, K.D. Kaufman, Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56, 45–62 (2005)PubMedCrossRef D.E. Moller, K.D. Kaufman, Metabolic syndrome: a clinical and molecular perspective. Annu. Rev. Med. 56, 45–62 (2005)PubMedCrossRef
2.
go back to reference K.L. Tamashiro, R.R. Sakai, C.A. Shively, I.N. Karatsoreos, L.P. Reagan, Chronic stress, metabolism, and metabolic syndrome. Stress 14(5), 468–474 (2011)PubMedCrossRef K.L. Tamashiro, R.R. Sakai, C.A. Shively, I.N. Karatsoreos, L.P. Reagan, Chronic stress, metabolism, and metabolic syndrome. Stress 14(5), 468–474 (2011)PubMedCrossRef
3.
go back to reference G.P. Chrousos, T. Kino, Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10, 213–219 (2007)PubMedCrossRef G.P. Chrousos, T. Kino, Glucocorticoid action networks and complex psychiatric and/or somatic disorders. Stress 10, 213–219 (2007)PubMedCrossRef
4.
go back to reference J. Zhou, J.A. Cidlowski, The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70, 407–417 (2005)PubMedCrossRef J. Zhou, J.A. Cidlowski, The human glucocorticoid receptor: one gene, multiple proteins and diverse responses. Steroids 70, 407–417 (2005)PubMedCrossRef
5.
go back to reference D. Duma, C.M. Jewell, J.A. Cidlowski, Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 102, 11–21 (2006)PubMedCrossRef D. Duma, C.M. Jewell, J.A. Cidlowski, Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J. Steroid Biochem. Mol. Biol. 102, 11–21 (2006)PubMedCrossRef
6.
go back to reference N.C. Nicolaides, Z. Galata, T. Kino, G.P. Chrousos, E. Charmandari, The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75, 1–12 (2010)PubMedCentralPubMedCrossRef N.C. Nicolaides, Z. Galata, T. Kino, G.P. Chrousos, E. Charmandari, The human glucocorticoid receptor: molecular basis of biologic function. Steroids 75, 1–12 (2010)PubMedCentralPubMedCrossRef
7.
go back to reference S.W. Lamberts, A.T. Huizenga, P. de Lange, F.H. de Jong, J.W. Koper, Clinical aspects of glucocorticoid sensitivity. Steroids 61, 157–160 (1996)PubMedCrossRef S.W. Lamberts, A.T. Huizenga, P. de Lange, F.H. de Jong, J.W. Koper, Clinical aspects of glucocorticoid sensitivity. Steroids 61, 157–160 (1996)PubMedCrossRef
8.
go back to reference P. Smit, H. Russcher, F.H. de Jong, A.O. Brinkmann, S.W. Lamberts, J.W. Koper, Differential regulation of synthetic glucocorticoids on gene expression levels of glucocorticoid-induced leucine zipper and interleukin-2. J. Clin. Endocrinol. Metab. 90, 2994–3000 (2005)PubMedCrossRef P. Smit, H. Russcher, F.H. de Jong, A.O. Brinkmann, S.W. Lamberts, J.W. Koper, Differential regulation of synthetic glucocorticoids on gene expression levels of glucocorticoid-induced leucine zipper and interleukin-2. J. Clin. Endocrinol. Metab. 90, 2994–3000 (2005)PubMedCrossRef
9.
go back to reference E.F. van Rossum, S.W. Lamberts, Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog. Horm. Res. 59, 333–357 (2004)PubMedCrossRef E.F. van Rossum, S.W. Lamberts, Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition. Recent Prog. Horm. Res. 59, 333–357 (2004)PubMedCrossRef
10.
go back to reference R.C. Lin, X.L. Wang, B. Dalziel, I.D. Caterson, B.J. Morris, Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes. Res. 11, 802–808 (2003)PubMedCrossRef R.C. Lin, X.L. Wang, B. Dalziel, I.D. Caterson, B.J. Morris, Association of obesity, but not diabetes or hypertension, with glucocorticoid receptor N363S variant. Obes. Res. 11, 802–808 (2003)PubMedCrossRef
11.
go back to reference R. Rosmond, Y.C. Chagnon, G. Holm, M. Chagnon, L. Pérusse, K. Lindell et al., A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes. Res. 8, 211–218 (2000)PubMedCrossRef R. Rosmond, Y.C. Chagnon, G. Holm, M. Chagnon, L. Pérusse, K. Lindell et al., A glucocorticoid receptor gene marker is associated with abdominal obesity, leptin, and dysregulation of the hypothalamic-pituitary-adrenal axis. Obes. Res. 8, 211–218 (2000)PubMedCrossRef
12.
go back to reference E.F. Van Rossum, J.W. Koper, N.A. Huizenga, A.G. Uitterlinden, J.A. Janssen, A.O. Brinkmann et al., A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51, 3128–3134 (2002)PubMedCrossRef E.F. Van Rossum, J.W. Koper, N.A. Huizenga, A.G. Uitterlinden, J.A. Janssen, A.O. Brinkmann et al., A polymorphism in the glucocorticoid receptor gene, which decreases sensitivity to glucocorticoids in vivo, is associated with low insulin and cholesterol levels. Diabetes 51, 3128–3134 (2002)PubMedCrossRef
13.
go back to reference E.F. Van Rossum, P.H. Roks, F.H. De Jong, A.O. Brinkmann, H.A. Pols, J.W. Koper et al., Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin. Endocrinol. (Oxf) 61, 573–581 (2004)CrossRef E.F. Van Rossum, P.H. Roks, F.H. De Jong, A.O. Brinkmann, H.A. Pols, J.W. Koper et al., Characterization of a promoter polymorphism in the glucocorticoid receptor gene and its relationship to three other polymorphisms. Clin. Endocrinol. (Oxf) 61, 573–581 (2004)CrossRef
14.
go back to reference E. Charmandari, T. Ichijo, W. Jubiz, S. Baid, K. Zachman, G.P. Chrousos et al., A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression. J. Clin. Endocrinol. Metab. 93, 4963–4968 (2008)PubMedCentralPubMedCrossRef E. Charmandari, T. Ichijo, W. Jubiz, S. Baid, K. Zachman, G.P. Chrousos et al., A novel point mutation in the amino terminal domain of the human glucocorticoid receptor (hGR) gene enhancing hGR-mediated gene expression. J. Clin. Endocrinol. Metab. 93, 4963–4968 (2008)PubMedCentralPubMedCrossRef
15.
go back to reference A.A. Syed, J.A. Irving, C.P. Redfern, A.G. Hall, N.C. Unwin, M. White et al., Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women. Obesity (Silver Spring) 14, 759–764 (2006)CrossRef A.A. Syed, J.A. Irving, C.P. Redfern, A.G. Hall, N.C. Unwin, M. White et al., Association of glucocorticoid receptor polymorphism A3669G in exon 9beta with reduced central adiposity in women. Obesity (Silver Spring) 14, 759–764 (2006)CrossRef
16.
go back to reference Porzezińska-Furtak J, Krzyżanowska-Świniarska B, Miazgowski T, Safranow K, Kamiński R. Hypothalamic-pituitary-adrenal axis activity, personality traits, and BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in metabolically obese normal-weight women. Endocrine. 45. doi:10.1007/s12020-014-0187-0 (2014) Porzezińska-Furtak J, Krzyżanowska-Świniarska B, Miazgowski T, Safranow K, Kamiński R. Hypothalamic-pituitary-adrenal axis activity, personality traits, and BCL1 and N363S polymorphisms of the glucocorticoid receptor gene in metabolically obese normal-weight women. Endocrine. 45. doi:10.​1007/​s12020-014-0187-0 (2014)
17.
go back to reference Y.X. Yan, J. Dong, L.J. Wu, S. Shao, J. Zhang, L. Zhang et al., Associations between polymorphisms in the glucocorticoid-receptor gene and cardiovascular risk factors in a Chinese population. J. Epidemiol. 23, 389–395 (2013)PubMedCentralPubMedCrossRef Y.X. Yan, J. Dong, L.J. Wu, S. Shao, J. Zhang, L. Zhang et al., Associations between polymorphisms in the glucocorticoid-receptor gene and cardiovascular risk factors in a Chinese population. J. Epidemiol. 23, 389–395 (2013)PubMedCentralPubMedCrossRef
18.
go back to reference K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato et al., Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645 (2009)PubMedCrossRef K.G. Alberti, R.H. Eckel, S.M. Grundy, P.Z. Zimmet, J.I. Cleeman, K.A. Donato et al., Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120, 1640–1645 (2009)PubMedCrossRef
19.
go back to reference J. Galon, D. Franchimont, N. Hiroi, G. Frey, A. Boettner, M. Ehrhart-Bornstein et al., Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB. J. 16, 61–71 (2002)PubMedCrossRef J. Galon, D. Franchimont, N. Hiroi, G. Frey, A. Boettner, M. Ehrhart-Bornstein et al., Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB. J. 16, 61–71 (2002)PubMedCrossRef
20.
go back to reference G.P. Chrousos, T. Kino, Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci. STKE. 2005, pe48 (2005)PubMed G.P. Chrousos, T. Kino, Intracellular glucocorticoid signaling: a formerly simple system turns stochastic. Sci. STKE. 2005, pe48 (2005)PubMed
21.
go back to reference P.J. Bray, R.G. Cotton, Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum. Mutat. 21, 557–568 (2003)PubMedCrossRef P.J. Bray, R.G. Cotton, Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum. Mutat. 21, 557–568 (2003)PubMedCrossRef
22.
go back to reference M. Panarelli, C.D. Holloway, R. Fraser, J.M. Connell, M.C. Ingram, N.H. Anderson et al., Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J. Clin. Endocrinol. Metab. 83, 1846–1852 (1998)PubMed M. Panarelli, C.D. Holloway, R. Fraser, J.M. Connell, M.C. Ingram, N.H. Anderson et al., Glucocorticoid receptor polymorphism, skin vasoconstriction, and other metabolic intermediate phenotypes in normal human subjects. J. Clin. Endocrinol. Metab. 83, 1846–1852 (1998)PubMed
23.
go back to reference M. Panek, T. Pietras, A. Fabijan, M. Milanowski, L. Wieteska, P. Górski, P. Kuna, J. Szemraj, Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes. Exp. Ther. Med. 5, 572–580 (2013)PubMedCentralPubMed M. Panek, T. Pietras, A. Fabijan, M. Milanowski, L. Wieteska, P. Górski, P. Kuna, J. Szemraj, Effect of glucocorticoid receptor gene polymorphisms on asthma phenotypes. Exp. Ther. Med. 5, 572–580 (2013)PubMedCentralPubMed
24.
go back to reference S.D. Detera-Wadleigh, I.J. Encio, D.Y. Rollins, D. Coffman, D. Wiesch, A Tth111I polymorphism on the 5′ flanking region of the glucocorticoid receptor gene (GRL). Nucleic Acids Res. 19, 1960 (1991)PubMedCentralPubMedCrossRef S.D. Detera-Wadleigh, I.J. Encio, D.Y. Rollins, D. Coffman, D. Wiesch, A Tth111I polymorphism on the 5′ flanking region of the glucocorticoid receptor gene (GRL). Nucleic Acids Res. 19, 1960 (1991)PubMedCentralPubMedCrossRef
25.
go back to reference E.F. Van Rossum, P.G. Voorhoeve, S.J. Te Velde, J.W. Koper, H.A.D. van de Waal, H.C. Kemper et al., The ER22, 23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J. Clin. Endocrinol. Metab. 89, 4004–4009 (2004)PubMedCrossRef E.F. Van Rossum, P.G. Voorhoeve, S.J. Te Velde, J.W. Koper, H.A.D. van de Waal, H.C. Kemper et al., The ER22, 23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J. Clin. Endocrinol. Metab. 89, 4004–4009 (2004)PubMedCrossRef
26.
go back to reference A. Krupoves, D. Mack, C. Deslandres, E. Seidman, D.K. Amre, Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency and resistance in children with Crohn’s disease. Pharmacogenet. Genomics 21, 454–460 (2011)PubMedCrossRef A. Krupoves, D. Mack, C. Deslandres, E. Seidman, D.K. Amre, Variation in the glucocorticoid receptor gene (NR3C1) may be associated with corticosteroid dependency and resistance in children with Crohn’s disease. Pharmacogenet. Genomics 21, 454–460 (2011)PubMedCrossRef
Metadata
Title
Polymorphisms in NR3C1 gene associated with risk of metabolic syndrome in a Chinese population
Authors
Yu-Xiang Yan
Jing Dong
Jie Zhang
Fen Liu
Wei Wang
Ling Zhang
Yan He
Publication date
01-12-2014
Publisher
Springer US
Published in
Endocrine / Issue 3/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0324-9

Other articles of this Issue 3/2014

Endocrine 3/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.